Skip to content
★ Sign in to follow
DG

Daniel G. Eramian

CTI Biopharma Corp
Total declarations
39
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (14 ops.)
€241k

Latest filing published 21 Sept 2012 for CTI Biopharma CORP, €31k.

Insider track record

Disclosed buys
0
Disclosed sells
14
Signal history

No signal scores available.

Daniel G. Eramian: trading record in brief

Daniel G. Eramian appears in our data through filings on CTI Biopharma Corp shares, published by SEC (Form 4). Over a trading history stretching from 31 March 2006 to 20 September 2012, the count stands at 39 filings.

Sales make up the whole of the open-market record (14 sales, €241k). Besides market trades, the filings include 22 share grants. Since January 2012: no purchases and 12 sales on the market.

Most recently, on 21 September 2012, the filings show an open-market sale worth €31k in CTI Biopharma Corp. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Daniel G. Eramian

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations35 total

25 of 35 declarations